17.6(top 1%)
2-year impact
1.7K(top 20%)
PR articles
132.1K(top 5%)
PR citations
169(top 2%)
PR h-index
187(top 2%)
h-index
17.5(top 1%)
2-YI (no self-cite.)
3.2K
documents
192.7K
doc citations

Top Articles

#TitleJournalYearCitations
1Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology20204,469
2Amyloid-β and TauJAMA Neurology20141,685
3Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic DrugsJAMA Neurology20181,131
4Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology2017787
5Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the PopulationJAMA Neurology2019684
6Inflammation and Neuroprotection in Traumatic Brain InjuryJAMA Neurology2015664
7Association of Amyloid and Tau With Cognition in Preclinical Alzheimer DiseaseJAMA Neurology2019653
8Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019JAMA Neurology2020633
9The Preclinical Alzheimer Cognitive CompositeJAMA Neurology2014622
10Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology2024597
11Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyJAMA Neurology2019592
12Seizures and Epileptiform Activity in the Early Stages of Alzheimer DiseaseJAMA Neurology2013563
13Sleep Quality and Preclinical Alzheimer DiseaseJAMA Neurology2013549
14Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain InjuryJAMA Neurology2019549
15Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer DiseaseJAMA Neurology2019544
16Current Concepts in Diagnosis and Treatment of Functional Neurological DisordersJAMA Neurology2018527
17Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical TrialsJAMA Neurology2020515
18Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer DiseaseJAMA Neurology2017491
19New Clinical Subtypes of Parkinson Disease and Their Longitudinal ProgressionJAMA Neurology2015489
20Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein AntibodiesJAMA Neurology2014484
21Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging BrainsJAMA Neurology2017479
22Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) CohortJAMA Neurology2017471
23Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumJAMA Neurology2021471
24Burden of Neurological Disorders Across the US From 1990-2017JAMA Neurology2021465
25Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With InfluenzaJAMA Neurology2020460
26Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer DiseaseJAMA Neurology2022441
27Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyJAMA Neurology2016439
28Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson DiseaseJAMA Neurology2016436
29Evaluation of Galcanezumab for the Prevention of Episodic MigraineJAMA Neurology2018431
30Association of Delirium With Long-term Cognitive DeclineJAMA Neurology2020431
31Association of Chronic Active Multiple Sclerosis Lesions With Disability In VivoJAMA Neurology2019423
32Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable TherapiesJAMA Neurology2020411
33Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain InjuryJAMA Neurology2016406
34Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the USJAMA Neurology2022399
35Global Prevalence and Incidence of TinnitusJAMA Neurology2022398
36Association of Proton Pump Inhibitors With Risk of DementiaJAMA Neurology2016392
37Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive ImpairmentJAMA Neurology2017374
38Vitamin D as an Early Predictor of Multiple Sclerosis Activity and ProgressionJAMA Neurology2014372
39Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease ProgressionJAMA Neurology2016370
40Self-reported Sleep and β-Amyloid Deposition in Community-Dwelling Older AdultsJAMA Neurology2013369
41Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer DiseaseJAMA Neurology2021369
42Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal FluidJAMA Neurology2017368
43Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson DiseaseJAMA Neurology2018367
44The Idiopathic Intracranial Hypertension Treatment TrialJAMA Neurology2014365
45Parkinson Disease SubtypesJAMA Neurology2014362
46Midlife Hypertension and 20-Year Cognitive ChangeJAMA Neurology2014354
47Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology2018345
48Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer DiseaseJAMA Neurology2018344
49Dementia Risk After Traumatic Brain Injury vs Nonbrain TraumaJAMA Neurology2014341
50Recovery After Mild Traumatic Brain Injury in Patients Presenting to US Level I Trauma CentersJAMA Neurology2019341